Valerylcarnitine
|
Basic information |
| Metabolite name | Valerylcarnitine |
 | HMDB0013128 |
 |
N/A |
 |
16226475 |
| Synonyms | NA |
| No. of studies | 4 |
|
Basic information |
| Metabolite name | Valerylcarnitine |
| HMDB0013128 |
|
N/A |
|
16226475 |
| Synonyms | NA |
| No. of studies | 4 |
|
Relationship between Valerylcarnitine and depression (count: 4) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1021 | Type1 | depression group vs. control group | Plasma | Human | Down |
| Study M741 | Type2 | MDD group, post vs. before SSRI treatment | Plasma | Human | Up |
| Study M741 | Type4 | remitter group vs. non-remitter group, posttreatment | Plasma | Human | Up |
| Study M741 | Type4 | remitter group vs. non-remitter group, baseline | Plasma | Human | Up |
| Study M779 | Type1 | depression group vs. control group | Plasma | Human | Up |
| Study M972 | Type1 | CRS + irradiation group vs. control group | Cerebral cortex | Sprague-Dawley rat | Up |
| Study M972 | Type2 | CRS + irradiation + paeoniflorin group vs. CRS + irradiation group | Cerebral cortex | Sprague-Dawley rat | Down |
| Study M972 | Type2 | CRS + irradiation + Paeoniae Radix Alba group vs. CRS + irradiation group | Cerebral cortex | Sprague-Dawley rat | Down |
| Study M972 | Type2 | CRS + irradiation + albiflorin group vs. CRS + irradiation group | Cerebral cortex | Sprague-Dawley rat | Down |